arginine has been researched along with metoprolol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carloni, C; Cristallini, S; Ferrandina, C; Filipponi, P; Gregorio, F; Moretti, I; Pietropaolo, M; Pippi, R | 1 |
| Ball, SG; Balmforth, AJ; Cuthbert, R; de Boer, RA; Greenwood, D; Hall, AS; Maqbool, A; van Veldhuisen, DJ; White, HL | 1 |
| Arcucci, O; Cipolletta, E; De Luca, N; Di Renzo, G; Iaccarino, G; Izzo, R; Lanni, F; Trimarco, V | 1 |
| Bogedain, P; Brodde, OE; Heusch, G; Jakob, HG; Leineweber, K; Philipp, T; Wagner, S; Weber, M; Wolf, C | 1 |
| Fici, F; Hekim, N; Oğuz, A; Uzunlulu, M; Yalçin, Y; Yorulmaz, E | 1 |
| Menevşe, E | 1 |
| Barlag, RE; Funovic, P; Jacob, RF; Korda, M; Kubant, R; Malinski, T; Mason, RP | 1 |
| Büssemaker, E; Hagedorn, C; Hausberg, M; Hillebrand, U; Kliche, K; Lang, D; Oberleithner, H; Pavenstädt, H; Reuter, S; Stock, CM; Telgmann, RG | 1 |
| Akgül, EO; Bilgi, C; Cakir, E; Cemri, M; Erbil, MK; Erdamar, H; Okyay, K; Poyraz, F; Sen, N; Tavil, Y; Turfan, M; Yazici, HU | 1 |
| Böhm, M; Hellmich, M; Huntgeburth, M; La Rosée, K; Rosenkranz, S; Schnabel, P; ten Freyhaus, H | 1 |
1 review(s) available for arginine and metoprolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for arginine and metoprolol
| Article | Year |
|---|---|
Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Arginine; Benzopyrans; Biomarkers; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Ethanolamines; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nebivolol; Prospective Studies; Treatment Outcome; Triglycerides | 2007 |
Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.
Topics: Adrenergic beta-Antagonists; Arginine; Benzopyrans; Blood Pressure; Cardiac Catheterization; Endothelium, Vascular; Ethanolamines; Exercise Test; Heart Rate; Humans; Metoprolol; Microvascular Angina; Nebivolol; Nitric Oxide; Single-Blind Method | 2009 |
The Arg389Gly β1-adrenoceptor gene polymorphism influences the acute effects of β-adrenoceptor blockade on contractility in the human heart.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Arginine; Echocardiography, Stress; Genotype; Glycine; Humans; Male; Metoprolol; Myocardial Contraction; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Receptors, Adrenergic, beta-1; Ventricular Function, Left | 2011 |
8 other study(ies) available for arginine and metoprolol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of beta non-selective and beta 1 selective adrenergic blocking agents on glucagon secretion from isolated perfused rat pancreas.
Topics: Animals; Arginine; Epinephrine; Glucagon; Insulin; Insulin Secretion; Islets of Langerhans; Male; Metoprolol; Models, Biological; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1986 |
An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study.
Topics: Adrenergic beta-Antagonists; Aged; Arginine; Blood Pressure; Female; Genotype; Glycine; Heart Failure; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta-1 | 2003 |
beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Antagonists; Alleles; Antihypertensive Agents; Arginine; Atenolol; Blood Glucose; Cholesterol; Female; Follow-Up Studies; Glutamic Acid; Homozygote; Humans; Hyperlipidemias; Hypertension; Male; Metoprolol; Polymorphism, Genetic; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Risk Factors; Triglycerides | 2005 |
In patients chronically treated with metoprolol, the demand of inotropic catecholamine support after coronary artery bypass grafting is determined by the Arg389Gly-beta 1-adrenoceptor polymorphism.
Topics: Adrenergic beta-Antagonists; Aged; Arginine; Blood Pressure; Cardiac Output; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Artery Disease; Epinephrine; Female; Glycine; Heart Rate; Heterozygote; Homozygote; Humans; Male; Metoprolol; Middle Aged; Norepinephrine; Polymorphism, Genetic; Receptors, Adrenergic, beta-1 | 2007 |
Effect of nebivolol and metoprolol treatments on serum asymmetric dimethlyarginine levels in hypertensive patients with type 2 diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Arginine; Benzopyrans; Confounding Factors, Epidemiologic; Diabetes Mellitus, Type 2; Ethanolamines; Humans; Hypertension; Metoprolol; Nebivolol | 2008 |
Effect of beta-blockers on endothelial function during biological aging: a nanotechnological approach.
Topics: Adrenergic beta-Antagonists; Aging; Animals; Aorta, Thoracic; Arginine; Atenolol; Cellular Senescence; Endothelium, Vascular; In Vitro Techniques; Metoprolol; Nanotechnology; Nitric Oxide; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Pterins; Rats; Rats, Inbred WKY; Superoxide Dismutase | 2008 |
Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Antihypertensive Agents; Arginine; Benzopyrans; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Size; Dose-Response Relationship, Drug; Drug Combinations; Elasticity; Endothelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogens; Ethanolamines; Female; Fulvestrant; Genes, Reporter; Humans; Metoprolol; Nanotechnology; Nebivolol; Nitric Oxide; Nitrites; Tamoxifen; Time Factors; Transfection | 2009 |